The 
AMR Industry Alliance launched its first report into the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR).

The Alliance brings together over 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations from 20 countries aiming to provide sustainable solutions to curb antimicrobial resistance.

Commenting on the launch, Dr David Pye, Honorary Policy Officer of the Biochemical Society and Derry Mercer member of the Biochemical Society's Policy Advisory Panel, said:
 
The Biochemical Society welcomes the recent ‘Progress Report’ published by the AMR Industry Alliance. Antimicrobial resistance is arguably one of the greatest threats to global health, and it is a challenge that cannot be tackled without the investment and involvement of industry. We are pleased to see the steps taken by the members of the AMR Industry Alliance to respond antimicrobial resistance, and we support the continuation of research and innovation in this field. We hope that AMR Industry Alliance continues to engage with its members to further develop the information and data gathered in this report’.